Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0YU1M
|
||||
Former ID |
DIB011026
|
||||
Drug Name |
G-207 virus construct
|
||||
Synonyms |
HrR3; G-207; G-47; G-47delta; G-207 virus construct, Catherex; G-207 virus construct, MediGene; HSV mutants (glioma), NCI; Oncolytic herpes simplex virus (glioma), Catherex/MediGene
|
||||
Indication | Glioma [ICD9: 191; ICD10:C71] | Phase 1/2 | [521499] | ||
Company |
MediGene Inc
|
||||
CAS Number |
CAS 126098-20-2
|
||||
Target and Pathway | |||||
Target(s) | Ribonucleoside-diphosphate reductase | Target Info | Inhibitor | [527093], [531689] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.